Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
IRADIMED CORPORATION (NASDAQ: IRMD)
IRMD Stock Predictions and Ratings
WSX Rating:
HOLD
WSX Forecast (1yr):
1.80%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-36.30%
IRMD Stock Analysis
IRMD
PE Ratio:
49.8
IRMD
PEG Ratio:
3.6
IRMD
Forward EPS Growth (12 month):
13.80%
IRMD
PS Ratio:
13.5
IRMD
PSG Ratio:
1.3
IRMD
Forward Revenue Growth (12 month):
10.50%
IRMD Articles
No data was found